Methods for screening for agonists and antagonists of GPI-anchored independent
intracellular signaling resulting in [Ca2+]i elevation, ERK1,
ERK2 and CREB phosphorylation, and Src family kinase activation are described,
as well as methods for treatment involving administration of agonists/antagonists
of such signaling.
